Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

NCT06941025 · clinicaltrials.gov ↗

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Fabry Disease
Pregnancy
Pregnancy Complications

Interventions

OTHER: Not applicable- observational study

Sponsor

Chiesi Farmaceutici S.p.A.

Collaborators

[object Object]